TOKYO -- U.S.-based Arch Venture Partners has launched a $3 billion venture capital fund specializing in medical technologies, one of the world's largest of its kind, with Japanese startups among its potential targets.
Biotechnology
American VC firm Arch launches $3bn biomedical fund with eye on Japan
Fund looks to help develop startups short on capital, co-founder says
